JPWO2019241535A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019241535A5
JPWO2019241535A5 JP2020568998A JP2020568998A JPWO2019241535A5 JP WO2019241535 A5 JPWO2019241535 A5 JP WO2019241535A5 JP 2020568998 A JP2020568998 A JP 2020568998A JP 2020568998 A JP2020568998 A JP 2020568998A JP WO2019241535 A5 JPWO2019241535 A5 JP WO2019241535A5
Authority
JP
Japan
Prior art keywords
aav
raav particles
feed composition
anion exchange
exchange chromatography
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020568998A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021526829A (ja
JP7385603B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/037013 external-priority patent/WO2019241535A2/en
Publication of JP2021526829A publication Critical patent/JP2021526829A/ja
Publication of JPWO2019241535A5 publication Critical patent/JPWO2019241535A5/ja
Application granted granted Critical
Publication of JP7385603B2 publication Critical patent/JP7385603B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020568998A 2018-06-14 2019-06-13 組換えaav生成のためのアニオン交換クロマトグラフィー Active JP7385603B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862684835P 2018-06-14 2018-06-14
US62/684,835 2018-06-14
PCT/US2019/037013 WO2019241535A2 (en) 2018-06-14 2019-06-13 Anion exchange chromatography for recombinant aav production

Publications (3)

Publication Number Publication Date
JP2021526829A JP2021526829A (ja) 2021-10-11
JPWO2019241535A5 true JPWO2019241535A5 (enExample) 2022-06-20
JP7385603B2 JP7385603B2 (ja) 2023-11-22

Family

ID=67513723

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020568998A Active JP7385603B2 (ja) 2018-06-14 2019-06-13 組換えaav生成のためのアニオン交換クロマトグラフィー

Country Status (9)

Country Link
US (2) US12070702B2 (enExample)
EP (1) EP3807405A2 (enExample)
JP (1) JP7385603B2 (enExample)
KR (1) KR102930150B1 (enExample)
CN (1) CN112469822A (enExample)
AU (1) AU2019285186B2 (enExample)
CA (1) CA3102817A1 (enExample)
IL (2) IL319002A (enExample)
WO (1) WO2019241535A2 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3387118B1 (en) 2015-12-11 2022-04-06 The Trustees Of The University Of Pennsylvania Scalable purification method for aavrh10
WO2017100676A1 (en) 2015-12-11 2017-06-15 The Trustees Of The University Of Pennsylvania Scalable purification method for aav8
US11098286B2 (en) 2015-12-11 2021-08-24 The Trustees Of The University Of Pennsylvania Scalable purification method for AAV9
DK3953483T3 (da) 2019-04-11 2023-12-18 Regenxbio Inc Fremgangsmåder til størrelseskromatografi til karakterisering af sammensætninger af rekombinant adeno-associeret virus
JP7630443B2 (ja) 2019-04-19 2025-02-17 レジェンクスバイオ インコーポレーテッド アデノ随伴ウイルスベクター製剤及び方法
WO2021158915A1 (en) * 2020-02-06 2021-08-12 Precision Biosciences, Inc. Recombinant adeno-associated virus compositions and methods for producing and using the same
EP4192437A4 (en) * 2020-08-07 2024-09-25 Janssen Biotech, Inc. FORMULATIONS FOR HIGHLY PURIFIED VIRAL PARTICLES
CN116234619A (zh) * 2020-08-18 2023-06-06 赛多利斯比亚分离有限责任公司 宿主细胞dna的金属亲和提取
AU2021356684A1 (en) 2020-10-09 2023-05-11 The Trustees Of The University Of Pennsylvania Compositions and methods for treatment of fabry disease
US20230383313A1 (en) 2020-10-18 2023-11-30 The Trustees Of The University Of Pennsylvania Improved adeno-associated virus (aav) vector and uses therefor
CN117042787A (zh) 2020-10-29 2023-11-10 宾夕法尼亚州大学信托人 Aav衣壳和含有aav衣壳的组合物
EP4240861A1 (en) * 2020-11-03 2023-09-13 Pfizer Inc. Methods for purification of aav vectors by anion exchange chromatography
KR20230120128A (ko) 2020-12-16 2023-08-16 리젠엑스바이오 인크. 재조합 바이러스 입자의 생산 방법
CA3205209A1 (en) 2021-01-21 2022-07-28 Regenxbio Inc. Improved production of recombinant polypeptides and viruses
WO2022159679A2 (en) * 2021-01-21 2022-07-28 Asklepios Biopharmaceutical, Inc. Method for purifying recombinant viral particles
JP7683230B2 (ja) * 2021-01-27 2025-05-27 東ソー株式会社 アデノ随伴ウイルスの精製方法
WO2022191168A1 (ja) * 2021-03-09 2022-09-15 Jcrファーマ株式会社 組換えaav9ビリオンの製造方法
WO2023060113A1 (en) 2021-10-05 2023-04-13 Regenxbio Inc. Compositions and methods for recombinant aav production
CN118202060A (zh) 2021-10-05 2024-06-14 再生生物股份有限公司 用于重组aav生产的组合物和方法
WO2023102517A1 (en) 2021-12-02 2023-06-08 The Trustees Of The University Of Pennsylvania Compositions and methods for treatment of fabry disease
CN114317464B (zh) * 2021-12-27 2023-07-04 武汉汇研生物科技股份有限公司 腺相关病毒rAAV9的分离纯化方法
US20250213727A1 (en) 2022-03-25 2025-07-03 Regenxbio Inc. Dominant-negative tumor necrosis factor alpha adeno-associated virus gene therapy
WO2023191827A1 (en) * 2022-03-28 2023-10-05 President And Fellows Of Harvard College High efficiency purification of divergent aav serotypes using aavx affinity chromatography
WO2023239627A2 (en) 2022-06-08 2023-12-14 Regenxbio Inc. Methods for recombinant aav production
US20260021205A1 (en) 2022-07-15 2026-01-22 The Trustees Of The University Of Pennsylvania Recombinant aav having aav clade d and clade e capsids and compositions containing same
WO2024038365A1 (en) * 2022-08-16 2024-02-22 Pfizer Inc. Methods for purification of aav vectors by anion exchange chromatography
WO2024211780A1 (en) 2023-04-07 2024-10-10 Regenxbio Inc. Compositions and methods for recombinant aav production
WO2024233529A2 (en) 2023-05-07 2024-11-14 Regenxbio Inc. Compositions and methods for recombinant aav production
JPWO2024242150A1 (enExample) * 2023-05-23 2024-11-28
CN121358869A (zh) * 2023-05-25 2026-01-16 朱诺治疗学股份有限公司 Aav纯化方法
US20240425825A1 (en) * 2023-06-20 2024-12-26 Regeneron Pharmaceuticals, Inc. Methods for purifying filled adeno-associated virus capsids
WO2025090962A1 (en) 2023-10-25 2025-05-01 Regenxbio Inc. Compositions and methods for recombinant aav production
US20250163468A1 (en) * 2023-11-21 2025-05-22 Regeneron Pharmaceuticals, Inc. Covalently surface modified adeno-associated virus production by in vitro conjugation, and purification of covalently surface modified adeno-associated virus
EP4606892A1 (en) * 2024-02-23 2025-08-27 Merck Patent GmbH Methods for the production of viral particles
WO2025226558A1 (en) * 2024-04-22 2025-10-30 Ultragenyx Pharmaceutical Inc. Multi-step filtration and clarification methods for recombinant adeno-associated virus purification
WO2025228321A1 (en) * 2024-04-29 2025-11-06 Skyline Therapeutics (Shanghai) Co., Ltd. METHOD OF SEPARATING RECOMBINANT ADENO-ASSOCIATED VIRUS (rAAV) PARTICLES

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6989264B2 (en) 1997-09-05 2006-01-24 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
ATE403715T1 (de) 1999-08-09 2008-08-15 Targeted Genetics Corp Erhöhung der expression einer einzelsträngigen, heterologen nukleotidsequenz von einem rekombinanten viralen vektor durch ausgestaltung der sequenz in einer art und weise, dass basenpaarungen innerhalb der sequenz entstehen
AU2911501A (en) 1999-12-29 2001-07-09 Genzyme Corporation Method using filtration aids for the separation of virus vectors from nucleic acids and other cellular contaminants
WO2002000337A1 (en) 2000-06-27 2002-01-03 Bia Separations D.O.O. A chromatography material and a process of manufacturing that material
US6593123B1 (en) 2000-08-07 2003-07-15 Avigen, Inc. Large-scale recombinant adeno-associated virus (rAAV) production and purification
US6723551B2 (en) 2001-11-09 2004-04-20 The United States Of America As Represented By The Department Of Health And Human Services Production of adeno-associated virus in insect cells
CN103555677B (zh) 2001-11-13 2018-01-30 宾夕法尼亚大学托管会 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法
WO2003052051A2 (en) 2001-12-17 2003-06-26 The Trustees Of The University Of Pennsylvania Adeno-associated virus (aav) serotype 8 sequences
ES2521682T3 (es) 2003-05-21 2014-11-13 Genzyme Corporation Procedimientos para producir preparaciones de viriones de AAV recombinantes sustancialmente exentas de cápsidas vacías
DK3211085T3 (da) 2003-09-30 2021-06-21 Univ Pennsylvania Klader af adeno-associeret virus (aav), sekvenser, vektorer indeholdende disse og anvendelser deraf
US7183969B2 (en) 2004-12-22 2007-02-27 Raytheon Company System and technique for calibrating radar arrays
US8999678B2 (en) 2005-04-07 2015-04-07 The Trustees Of The University Of Pennsylvania Method of increasing the function of an AAV vector
US7456683B2 (en) 2005-06-09 2008-11-25 Panasonic Corporation Amplitude error compensating device and quadrature skew error compensating device
AU2009209408B2 (en) 2008-01-29 2015-06-11 Beacon Therapeutics Limited Recombinant virus production using mammalian cells in suspension
CA2715924C (en) 2008-02-19 2021-01-12 Andrew Christian BAKKER Optimisation of expression of parvoviral rep and cap proteins in insect cells
ES2724122T3 (es) 2009-04-30 2019-09-06 Univ Pennsylvania Composiciones para dirigir células de las vías respiratorias de conducción que comprenden construcciones de virus adenoasociado
WO2010138263A2 (en) 2009-05-28 2010-12-02 University Of Massachusetts Novel aav 's and uses thereof
US8628966B2 (en) 2010-04-30 2014-01-14 City Of Hope CD34-derived recombinant adeno-associated vectors for stem cell transduction and systemic therapeutic gene transfer
US8927514B2 (en) 2010-04-30 2015-01-06 City Of Hope Recombinant adeno-associated vectors for targeted treatment
EP2634253B1 (en) 2010-10-27 2016-05-11 Jichi Medical University Adeno-associated virus virions for transferring genes into neural cells
JP6042825B2 (ja) 2011-02-10 2016-12-14 ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル 改変された形質導入プロファイルを有するウイルスベクターならびにその製造および使用の方法
DK4005603T3 (da) 2011-04-22 2024-11-25 Univ California Adeno-associerede virus-virioner med variant kapsid og fremgangsmåder til anvendelse heraf
US9169299B2 (en) 2011-08-24 2015-10-27 The Board Of Trustees Of The Leleand Stanford Junior University AAV capsid proteins for nucleic acid transfer
WO2013170078A1 (en) 2012-05-09 2013-11-14 Oregon Health & Science University Adeno associated virus plasmids and vectors
EP2970946A4 (en) 2013-03-13 2016-09-07 Philadelphia Children Hospital ADENOASSOZED VIRUS VECTORS AND METHOD FOR USE THEREOF
EP2986632B1 (en) 2013-04-20 2018-09-05 Research Institute at Nationwide Children's Hospital Recombinant adeno-associated virus delivery of exon 2-targeted u7snrna polynucleotide constructs
CA3209883A1 (en) 2013-07-22 2015-01-29 The Children's Hospital Of Philadelphia Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues
US9585971B2 (en) 2013-09-13 2017-03-07 California Institute Of Technology Recombinant AAV capsid protein
ES2857751T3 (es) 2013-10-11 2021-09-29 Massachusetts Eye & Ear Infirmary Métodos para predecir secuencias de virus ancestrales y usos de los mismos
WO2015164757A1 (en) 2014-04-25 2015-10-29 Oregon Health & Science University Methods of viral neutralizing antibody epitope mapping
WO2015191508A1 (en) 2014-06-09 2015-12-17 Voyager Therapeutics, Inc. Chimeric capsids
KR20230067694A (ko) 2014-09-24 2023-05-16 시티 오브 호프 고효율 게놈 편집을 위한 아데노-관련 바이러스 벡터 변이체 및 이의 방법
EP3054007A1 (en) 2015-02-09 2016-08-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step
JP6665466B2 (ja) 2015-09-26 2020-03-13 日亜化学工業株式会社 半導体発光素子及びその製造方法
WO2017070491A1 (en) 2015-10-23 2017-04-27 Applied Genetic Technologies Corporation Ophthalmic formulations
US11098286B2 (en) 2015-12-11 2021-08-24 The Trustees Of The University Of Pennsylvania Scalable purification method for AAV9
EP3387118B1 (en) 2015-12-11 2022-04-06 The Trustees Of The University Of Pennsylvania Scalable purification method for aavrh10
WO2017100676A1 (en) * 2015-12-11 2017-06-15 The Trustees Of The University Of Pennsylvania Scalable purification method for aav8
US11015173B2 (en) * 2015-12-11 2021-05-25 The Trustees Of The University Of Pennsylvania Scalable purification method for AAV1
CN109463017A (zh) 2016-03-14 2019-03-12 佩鲁马拉有限公司 间歇和连续地再循环光的光伏系统
WO2019178495A1 (en) * 2018-03-16 2019-09-19 Biogen Ma Inc. Methods for purifying recombinant adeno-associated viruses

Similar Documents

Publication Publication Date Title
JPWO2019241535A5 (enExample)
US12351832B2 (en) Recombinant adeno-associated virus particle purification with multiple-step anion exchange chromatography
EP3256574B1 (en) Recombinant adeno-associated virus particle purification comprising an affinity purification step
US20220364111A1 (en) Methods for producing preparations of recombinant aav virions substantially free of empty capsids
JP2024009857A5 (enExample)
JP2018510648A5 (enExample)
JP2021118724A5 (enExample)
JP2018522529A5 (enExample)
JP2019533803A5 (enExample)
JP2017509632A5 (enExample)
JP2020519284A5 (enExample)
JPWO2020214609A5 (enExample)
JPWO2019173538A5 (enExample)
JPWO2020168222A5 (enExample)
JPWO2020081490A5 (enExample)
JPWO2022032104A5 (enExample)
JPWO2021221995A5 (enExample)
JPWO2022261663A5 (enExample)
JPWO2022204670A5 (enExample)
JPWO2022159662A5 (enExample)
RU2025127724A (ru) Молекула нуклеиновой кислоты, содержащая асимметрично модифицированный ITR для повышения уровня экспрессии встроенного гена, и ее применение
RU2023135618A (ru) Методы колоночной очистки вектора aav
CA2975569C (en) Recombinant adeno-associated virus particle purification comprising an affinity purification step
RU2022115853A (ru) Нуклеиновая кислота, имеющая промоторную активность, и ее применение
HK1227435A1 (en) Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step